title: Hydrogen water intake via tube-feeding for patients with pressure ulcer and its reconstructive effects on normal human skin cells in vitro.
abstract: BACKGROUND
  Pressure ulcer (PU) is common in immobile elderly patients, and there are some research works to investigate a preventive and curative method, but not to find sufficient effectiveness. The aim of this study is to clarify the clinical effectiveness on wound healing in patients with PU by hydrogen-dissolved water (HW) intake via tube-feeding (TF). Furthermore, normal human dermal fibroblasts OUMS-36 and normal human epidermis-derived cell line HaCaT keratinocytes were examined in vitro to explore the mechanisms relating to whether hydrogen plays a role in wound-healing at the cellular level.
  
  
  METHODS
  Twenty-two severely hospitalized elderly Japanese patients with PU were recruited in the present study, and their ages ranged from 71.0 to 101.0 (86.7 ± 8.2) years old, 12 male and 10 female patients, all suffering from eating disorder and bedridden syndrome as the secondary results of various underlying diseases. All patients received routine care treatments for PU in combination with HW intake via TF for 600 mL per day, in place of partial moisture replenishment. On the other hand, HW was prepared with a hydrogen-bubbling apparatus which produces HW with 0.8-1.3 ppm of dissolved hydrogen concentration (DH) and -602 mV to -583 mV of oxidation-reduction potential (ORP), in contrast to reversed osmotic ultra-pure water (RW), as the reference, with DH of < 0.018 ppm and ORP of +184 mV for use in the in vitro experimental research. In in vitro experiments, OUMS-36 fibroblasts and HaCaT keratinocytes were respectively cultured in medium prepared with HW and/or RW. Immunostain was used for detecting type-I collagen reconstruction in OUMS-36 cells. And intracellular reactive oxygen species (ROS) were quantified by NBT assay, and cell viability of HaCaT cells was examined by WST-1 assay, respectively.
  
  
  RESULTS
  Twenty-two patients were retrospectively divided into an effective group (EG, n = 12) and a less effective group (LG, n = 10) according to the outcomes of endpoint evaluation and the healing criteria. PU hospitalized days in EG were significantly shorter than in LG (113.3 days vs. 155.4 days, p < 0.05), and the shortening rate was approximately 28.1%. Either in EG or in LG, the reducing changes (EG: 91.4%; LG: 48.6%) of wound size represented statistically significant difference versus before HW intake (p < 0.05, p < 0.001). The in vitro data demonstrate that intracellular ROS as quantified by NBT assay was diminished by HW, but not by RW, in ultraviolet-A (UVA)-irradiated HaCaT cells. Nuclear condensation and fragmentation had occurred for UVA-irradiated HaCaT cells in RW, but scarcely occurred in HW as demonstrated by Hoechst 33342 staining. Besides, under UVA-irradiation, either the mitochondrial reducing ability of HaCaT cells or the type-I collagen construction in OUMS-36 cells deteriorated in RW-prepared culture medium, but was retained in HW-prepared culture medium as shown by WST-1 assay or immunostain, respectively.
  
  
  CONCLUSIONS
  HW intake via TF was demonstrated, for severely hospitalized elderly patients with PU, to execute wound size reduction and early recovery, which potently ensue from either type-I collagen construction in dermal fibroblasts or the promoted mitochondrial reducing ability and ROS repression in epidermal keratinocytes as shown by immunostain or NBT and WST-1 assays, respectively.
authors.affiliation: Department of Radiological Technology, Faculty of Health Sciences, Butsuryo College of Osaka, Otorikitamachi 3-33, Nishi-ku, Sakai, Osaka 593-8328, Japan. miwa@butsuryo.ac.jp.
authors.forename: Qiang
authors.initials: Q
authors.lastname: Li
authors.forename: Shinya
authors.initials: S
authors.lastname: Kato
authors.forename: Daigo
authors.initials: D
authors.lastname: Matsuoka
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Tanaka
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Miwa
references.citation: Biochem Biophys Res Commun. 2008 Dec 26;377(4):1195-8
references.pmid: 18996093
references.citation: Exp Physiol. 2010 Dec;95(12):1107-30
references.pmid: 20851859
references.citation: Toxicol Ind Health. 2010 May;26(4):203-16
references.pmid: 20203135
references.citation: Wound Repair Regen. 2011 Sep-Oct;19(5):559-67
references.pmid: 22092794
references.citation: Int J Tissue React. 1988;10(6):373-9
references.pmid: 2475452
references.citation: Kidney Int. 2010 Jan;77(2):101-9
references.pmid: 19907413
references.citation: Biomed Pharmacother. 2010 Oct;64(8):565-71
references.pmid: 20347571
references.citation: Med Gas Res. 2012 Oct 02;2(1):27
references.pmid: 23031079
references.citation: Nat Med. 2007 Jun;13(6):688-94
references.pmid: 17486089
references.citation: Nutr Res. 2008 Mar;28(3):137-43
references.pmid: 19083400
references.citation: Exp Oncol. 2009 Sep;31(3):156-62
references.pmid: 19783965
references.citation: J Cell Biochem. 2004 Oct 15;93(3):588-97
references.pmid: 15378602
references.citation: J Photochem Photobiol B. 2012 Jan 5;106:24-33
references.pmid: 22070900
references.citation: Int Wound J. 2011 Oct;8(5):522-32
references.pmid: 21914133
references.citation: Oncol Res. 2008;17(6):247-55
references.pmid: 19192719
references.citation: Transpl Int. 2012 Dec;25(12):1213-22
references.pmid: 22891787
references.citation: Biochem Biophys Res Commun. 2007 Sep 28;361(3):670-4
references.pmid: 17673169
references.citation: J Long Term Eff Med Implants. 2004;14(4):285-304
references.pmid: 15447627
references.citation: Cell. 2011 Nov 11;147(4):742-58
references.pmid: 22078876
references.citation: Cardiovasc Res. 2012 Apr 1;94(1):144-53
references.pmid: 22287575
references.citation: Sci Signal. 2010 Oct 26;3(145):re8
references.pmid: 20978240
references.citation: Int J Biol Sci. 2008 Feb 19;4(2):63-70
references.pmid: 18311331
references.citation: Nat Med. 2007 Jun;13(6):673-4
references.pmid: 17554332
references.citation: J Invest Dermatol. 2009 Apr;129(4):851-61
references.pmid: 19037237
references.citation: JAMA. 2006 Aug 23;296(8):1020
references.pmid: 16926361
references.citation: J Photochem Photobiol B. 2011 Jan 10;102(1):69-76
references.pmid: 20943412
references.citation: Nurs Clin North Am. 1999 Dec;34(4):861-71, vi
references.pmid: 10523439
references.citation: Neurosci Lett. 2008 Aug 22;441(2):167-72
references.pmid: 18603371
references.citation: Cancer Chemother Pharmacol. 2009 Sep;64(4):753-61
references.pmid: 19148645
references.citation: Biochem Biophys Res Commun. 2009 Aug 14;386(1):11-5
references.pmid: 19486890
references.citation: J Nanosci Nanotechnol. 2012 May;12(5):4019-27
references.pmid: 22852342
references.citation: Wound Repair Regen. 2011 May-Jun;19(3):309-15
references.pmid: 21539648
references.citation: PLoS One. 2009 Sep 30;4(9):e7247
references.pmid: 19789628
references.citation: Oncol Rep. 2010 Dec;24(6):1463-70
references.pmid: 21042740